Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8755558 | 1.00 | SMN1; SMN2 (0.32) | SMN1; SMN2MEN1CYP1A2KMT2AKDM4E | |
| SCHEMBL18597314 | 0.94 | — | — | |
| SCHEMBL8755597 | 0.93 | — | — | |
| SCHEMBL11726259 | 0.90 | EPHX1 (0.45) | — | |
| SCHEMBL1937316 | 0.90 | EPHX1 (0.45) | — | |
| SCHEMBL1937986 | 0.90 | EPHX1 (0.45) | — | |
| SCHEMBL1937657 | 0.90 | EPHX1 (0.45) | — | |
| SCHEMBL11810751 | 0.90 | EPHX1 (0.45) | — | |
| SCHEMBL12669343 | 0.90 | EPHX1 (0.45) | — | |
| SCHEMBL11125409 | 0.90 | EPHX1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210087337-A1 | COMPOUNDS, COMPOSITIONS AND METHODS RELATED TO ANTIMICROBIAL APPLICATIONS | VYOME THERAPEUTICS LIMITED (IN) | 2021-03-25 | — | — | US | claimed |
| US-20190373895-A1 | BRANCHED POLYMERIC BIGUANIDE COMPOUNDS AND THEIR USES | CHEN HWANG HSING (US) | 2019-12-12 | — | — | US | claimed |
| EP-2306816-B1 | Use of topical compositions for the preservation of a human or animal body | ARKEMA FRANCE (FR) | 2015-04-08 | — | — | EP | claimed |
| US-20110104097-A1 | TOPICAL COMPOSITIONS FOR THE PRESERVATION OF A HUMAN OR ANIMAL BODY | ARKEMA FRANCE (FR) | 2011-05-05 | — | — | US | claimed |
| JP-1071846-A | — | — | None | — | — | JP | disclosed |
| US-20250359547-A1 | ALKOXYLATED ALKANOLS FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS | BASF SE (DE) | 2025-11-27 | — | — | US | disclosed |
| WO-2024013193-A1 | ALKOXYLATED ALKANOLS FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS | BASF SE (DE) | 2024-01-18 | — | — | WO | disclosed |
| WO-2023170160-A1 | POLYMERIC IMIDAZOLIUM COMPOUNDS FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS | BASF SE (DE) | 2023-09-14 | — | — | WO | disclosed |
| US-11044912-B2 | Branched polymeric biguanide compounds and their uses | CHEN HWANG HSING (US) | 2021-06-29 | — | — | US | disclosed |
| EP-3040007-B2 | BIOCIDE-FREE, PREWETTED SPONGE CLOTH | KALLE GMBH (DE) | 2021-06-16 | — | — | EP | disclosed |
| US-20210087337-A1 | COMPOUNDS, COMPOSITIONS AND METHODS RELATED TO ANTIMICROBIAL APPLICATIONS | VYOME THERAPEUTICS LIMITED (IN) | 2021-03-25 | — | — | US | disclosed |
| US-20210087337-A1 | COMPOUNDS, COMPOSITIONS AND METHODS RELATED TO ANTIMICROBIAL APPLICATIONS | VYOME THERAPEUTICS LIMITED (IN) | 2021-03-25 | — | — | US | disclosed |
| EP-0668885-A4 | POLYMERIC BIGUANIDES. | STOCKEL RICHARD F (US) | 1998-09-30 | — | — | EP | disclosed |
| EP-0643044-B1 | Bis-biguanide compound useful as a disinfectant | MITSUBISHI MATERIALS CORP (JP) | 1997-05-07 | — | — | EP | disclosed |
| EP-0668885-A1 | POLYMERIC BIGUANIDES | STOCKEL, Richard F. (US) | 1995-08-30 | — | — | EP | disclosed |
| EP-0305721-B1 | PROCESS FOR PREPARING HEXAMETHYLENE BIS-DICYANIDE DIAMIDE | Degussa Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | disclosed |
| WO-1990011315-A1 | POLYMERIC BIGUANIDES | STOCKEL RICHARD F (US) | 1990-10-04 | — | — | WO | disclosed |
| EP-0305721-A1 | Process for preparing hexamethylene bis-dicyanide diamide | Degussa Aktiengesellschaft (DE) | 1989-03-08 | — | — | EP | disclosed |
| EP-0232250-A1 | METHODS AND SOLUTION FOR DESINFECTING AND PRESERVING CONTACT LENSES. | BAUSCH & LOMB (US) | 1987-08-19 | — | — | EP | disclosed |
| WO-1987000437-A1 | METHODS FOR DESINFECTING AND PRESERVING CONTACT LENSES | BAUSCH & LOMB INCORPORATED (US) | 1987-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250359547-A1 | ALKOXYLATED ALKANOLS FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS | CAT, LPO, ALKBH1 | SMN1; SMN2 3729/4885MEN1 3783/4885CYP1A2 158/4885 |
| US-11044912-B2 | Branched polymeric biguanide compounds and their uses | PUF60, XRCC6, PCNA | SMN1; SMN2 3255/4885MEN1 975/4885CYP1A2 1462/4885 |
| US-20190373895-A1 | BRANCHED POLYMERIC BIGUANIDE COMPOUNDS AND THEIR USES | PUF60, XRCC6, PCNA | SMN1; SMN2 3255/4885MEN1 975/4885CYP1A2 1462/4885 |
| US-20210087337-A1 | COMPOUNDS, COMPOSITIONS AND METHODS RELATED TO ANTIMICROBIAL APPLICATIONS | CUTA, GMPS, MMP8 | SMN1; SMN2 3207/4885MEN1 4743/4885CYP1A2 2367/4885 |
| US-20110104097-A1 | TOPICAL COMPOSITIONS FOR THE PRESERVATION OF A HUMAN OR ANIMAL BODY | FUCA1, PIGS, UNG | SMN1; SMN2 941/4885MEN1 2840/4885CYP1A2 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.